EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 22-Jun-2026 03:16 ET (22-Jun-2026 07:16 GMT/UTC)

Research advances toward more effective, long-lasting and side effect-free cancer treatments

Baylor College of Medicine
Peer-Reviewed Publication

Researchers at Baylor College of Medicine are building the case for SRC-3 as a promising therapeutic target for next-generation cancer immunotherapy.

Journal: OncoImmunology

Irish researchers aim to revolutionise bowel cancer detection with new blood test

Trinity College Dublin
Grant and Award Announcement

Researchers from Trinity College Dublin, Dublin City University and University College Dublin will use newly awarded funding of €670,000 from Enterprise Ireland’s Commercialisation Fund to develop a breakthrough blood-based screening test for bowel cancer (colorectal cancer, CRC).

The team, working with clinicians at St. Vincent’s University Hospital, seeks to transform cancer outcomes by moving screening away from invasive or unpleasant methods to their simple, high-accuracy blood test, named “CASPDx CRC”.

The CASPDx team is now initiating the formal validation of their product. Patients are being recruited in all Bowel Screen Centres in the HSE Dublin & South East region as part of clinical validation studies, with assistance of the UCD Clinical Research Centre. While the CASPDx CRC test is still at clinical validation and immunoassay development phases, the team aim to launch the test and spin-out as a company by the end of 2027.

Funder: Enterprise Ireland

Protein modification discovery opens cancer therapy possibilities

Purdue University
Peer-Reviewed Publication

A research team led by Purdue University’s W. Andy Tao has discovered of a new type of protein modification related to cellular mutation that impairs a crucial enzyme’s ability to help drive energy processes. Their discovery, reported in Nature Chemistry, opens a new route to therapeutic cancer intervention.

Journal: Nature Chemistry

International Journal of Disease Reversal and Prevention publishes clinicians guide: Latest research on role of dietary interventions in cancer, menopause, Alzheimer’s disease, and others

Physicians Committee for Responsible Medicine
Peer-Reviewed Publication

A summary of the presentations and findings of the International Conference on Nutrition in Medicine (ICNM), the annual meeting conducted by the Physicians Committee for Responsible Medicine, was published today in the International Journal of Disease Reversal and Prevention. Clinicians now have ready access to the latest information regarding the role of dietary interventions in breast and prostate cancers, menopause, and Alzheimer’s disease, among others.

Journal: International Journal of Disease Reversal and Prevention

Obesity control’s underestimated potential for cancer prevention

JAMA Network
Peer-Reviewed Publication

About The Article: This Viewpoint discusses obesity prevention and control as an underestimated and underutilized strategy in the prevention of numerous cancers.

Journal: JAMA Oncology

Triple combination therapy before surgery helps boost immunity against aggressive soft tissue sarcomas

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

The findings, published in Cancer Discovery, show that the approach can reshape the tumor microenvironment to activate the body’s immune cells against cancer.

Journal: Cancer Discovery

£43M AI cardio-oncology initiative kicks off with King's College London as academic lead

King's College London
Grant and Award Announcement

A new consortium, bringing together more than 60 partners from 25 countries, has kicked off a five-year initiative to help improve the heart health of people living with and beyond cancer with a two-day meeting at St Thomas' Hospital and the London Institute for Healthcare Engineering.

Prostate Cancer Foundation awards grants to Weill Cornell Medicine investigators

Weill Cornell Medicine
Grant and Award Announcement

Six researchers from Weill Cornell Medicine have received Young Investigator Awards from the Prostate Cancer Foundation. These three-year grants award $225,000 to postdoctoral fellows and early-career faculty, helping to energize the field with fresh ideas.

Immunotherapy boosts chemotherapy in combating stage 3 colon cancer

Mayo Clinic
Peer-Reviewed Publication

New research led by Mayo Clinic Comprehensive Cancer Center found that adding immunotherapy to chemotherapy after surgery for patients with stage 3 (node-positive) colon cancer — and with a specific genetic makeup called deficient DNA mismatch repair (dMMR) — was associated with a 50% reduction in cancer recurrence and mortality compared to chemotherapy alone.

Journal: New England Journal of Medicine

Ludwig Lausanne’s Ping-Chih Ho elected AAAS Fellow

Ludwig Institute for Cancer Research
Grant and Award Announcement

Our congratulations to Ludwig Lausanne’s Ping-Chih Ho, who has been elected Fellow of the American Association for the Advancement of Science (AAAS).

Funder: American Association for the Advancement of Science